Clinical Trial Update: Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating alvocidib in adults with locally advanced or metastatic solid tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Alvocidib (Flavopiridol)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Status: TERMINATED